GSK commits $30 billion to US research and development, factory expansion, as Trump visits UK

Drugmaker GSK said Wednesday it would invest $30 billion in U.S. research and development and supply chain infrastructure over five years, after U.S. President Donald Trump arrived in Britain for a second state visit to seal investment deals.